Anthem Inc (ANTM – Q4FY19 & FY19)- Launch of IngenioRx is a key milestone to the growth

in , on February 27, 2020

Anthem successfully completed the IngenioRx migration, transitioning more than 15mn people over
the past 8 months. The launch of IngenioRx is a key milestone for the growth of the company as they expect huge revenues growth in coming quarters.

Executive Summary
 Financial Statements
– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Q4FY19 & FY19 Results – Overview
– Q4FY19 – Membership
– Q4FY19 – Segment Performance
– FY20 Guidance
– Conclusion
– GAAP to Non-GAAP Reconciliation
Historical Performance
– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– DuPont Analysis
– Return on Invested Capital
– Per Share Items and Key ratios
– Key Cash Flow Items
– P/E Band
 Product Performance and Key Developments
– Ownership
– Competitors
– Key Developments
Valuation and Consensus Performance
– Relative Valuation
– Analyst Recommendations
Market Price Performance
CrispIdea Coverage

Release Information

  • Released
    :

    February 27, 2020

  • Last Updated
    :

    February 28, 2020